Navamedic ASA

kr 10.25As of Sun 8 Nov 2026, 12:00 UTC
OSL:NAVAHealthcare
Country Norway
PE (Fwd) •••
TSR 10Y CAGR (2.96%)
Div yield —
ROE (10.02%)
Medical Distribution
Beta (5Y) 0.25
PE TTM —
TSR TTM (52.10%)
Mkt cap kr 245.8M
ROIC (0.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 11
11.83%
71.37%
Hold 5|2|2|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.21
0.20
0.19
0.20
16.42%
1.83%
(4.15%)
(0.99%)
Revenuekr M
16.97
17.66
17.21
18.01
(4.44%)
1.62%
(1.16%)
4.12%
Peers (US$26.00M)
Cap (US$)
PE
205.3M
—
97.40M
—
9.905M
—
25.51M
—
Capital
TTM
5Y
10Y
Leveragex
1.094
(0.485)
(0.356)
EBIT/Intx
5.303
0.358
0.290
Own earn%
(25.37)
(74.36)
(74.42)
Sh yield%
30.59
12.27
12.37
Owners
Insiders/Inst%
13.37
76.85
Short interest%
2.37
SBC / revenue%
5.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
21–29
$1 testx
0.1
Incr. ROIC%
7